Millennium reports 3.38M-share passive stake in Vanda (NASDAQ: VNDA)

Rhea-AI Filing Summary

Vanda Pharmaceuticals Inc. (VNDA) is reported to have a significant shareholder group consisting of Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. These reporting persons collectively report beneficial ownership of 3,376,401 shares of Vanda common stock, representing 5.6% of the outstanding class.

They report shared voting and shared dispositive power over all 3,376,401 shares, and no sole voting or dispositive power. The shares are held by entities over which Millennium Management LLC and related managers have voting control and investment discretion, and the reporting persons state that this should not, by itself, be construed as an admission of beneficial ownership.

Key Figures

Shares beneficially owned: 3,376,401 shares Percent of class: 5.6% Sole voting power: 0 shares +3 more

6 metrics

Shares beneficially owned 3,376,401 shares Common stock of Vanda Pharmaceuticals Inc. reported on Schedule 13G

Percent of class 5.6% Ownership percentage of Vanda common stock reported by the filing group

Sole voting power 0 shares Shares over which the reporting persons have sole voting power

Shared voting power 3,376,401 shares Shares over which the reporting persons have shared voting power

Sole dispositive power 0 shares Shares over which the reporting persons have sole dispositive power

Shared dispositive power 3,376,401 shares Shares over which the reporting persons have shared dispositive power

Key Terms

beneficially owned, shared voting power, shared dispositive power, Schedule 13G, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: See response to Item 9 on each cover page."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"Shared Voting Power 3,376,401.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 3,376,401.00"

Schedule 13G regulatory

"form_type: SCHEDULE 13G"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Joint Filing Agreement regulatory

"Exhibit I: Joint Filing Agreement, dated as of August 18, 2026"

FAQ

What stake does Millennium Management report in Vanda Pharmaceuticals Inc. (VNDA)?

Millennium Management and related reporting persons report beneficial ownership of 3,376,401 VNDA shares, representing 5.6% of the company’s common stock. They hold only shared voting and dispositive power over these shares, with no sole authority reported.

Who are the reporting persons on this Schedule 13G for VNDA?

The reporting persons are Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. They jointly report shared voting and dispositive power over 3,376,401 shares of Vanda Pharmaceuticals Inc. common stock under this Schedule 13G.

What percentage of Vanda Pharmaceuticals Inc. (VNDA) does 3,376,401 shares represent?

The filing states that 3,376,401 shares of Vanda Pharmaceuticals Inc. common stock represent 5.6% of the outstanding class. This percentage reflects the reporting group’s beneficial ownership position as disclosed in the Schedule 13G.

Do the Millennium entities have sole or shared voting power over VNDA shares?

The reporting persons disclose 0 shares with sole voting power and 3,376,401 shares with shared voting power. They likewise report 0 shares with sole dispositive power and shared dispositive power over all 3,376,401 shares of VNDA common stock.

How do the reporting persons describe their beneficial ownership of VNDA?

They state the securities are held by entities subject to their voting control and investment discretion, but clarify that this should not be construed as an admission of beneficial ownership of the securities held by those entities for legal and reporting purposes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 06:33 PM Accepted by SEC EDGAR 08/19/2026 - 06:32 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Vanda Pharmaceuticals Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

921659108

(CUSIP Number)

08/17/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 921659108

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,376,401.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,376,401.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,376,401.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 921659108

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,376,401.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,376,401.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,376,401.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 921659108

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,376,401.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,376,401.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,376,401.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Vanda Pharmaceuticals Inc.
(b)	Address of issuer's principal executive offices: 2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037
Item 2.
(a)	Name of person filing: Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP Number(s): 921659108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	08/18/2026

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	08/18/2026

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	08/18/2026

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of August 18, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.